Upregulated CXCL5 in patients with cervical cancer increases the oncogenic potential of HeLa cervical cancer cells by increasing the phosphorylation of ERK1/2 and Akt and the gene expression of CXCR2 [36]. Here, MAPK3 is linked to cervical cancer.